These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2828727)

  • 21. Effect of ketamine on control of breathing in cats.
    Jaspar N; Mazzarelli M; Tessier C; Milic-Emili J
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Sep; 55(3):851-9. PubMed ID: 6415013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats.
    Baraban SC; Stornetta RL; Guyenet PG
    J Pharmacol Exp Ther; 1993 Apr; 265(1):89-95. PubMed ID: 8474034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei.
    Hassen AH; Feuerstein G; Faden AI
    Peptides; 1983; 4(5):621-5. PubMed ID: 6318199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different laryngeal responses during respiratory arrest produced by hypoxia withdrawal, thiopentone, ketamine, and lidocaine in cats.
    Nishino T; Yonezawa T; Honda Y
    Anesthesiology; 1982 Apr; 56(4):280-5. PubMed ID: 7065436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin induced apnoea: prevention by central and peripheral administration of the opiate receptor blocking agent naloxone.
    Härfstrand A; Fuxe K; Kalia M; Agnati LF
    Acta Physiol Scand; 1985 Sep; 125(1):91-5. PubMed ID: 2864786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two kinds of opiate receptor.
    Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):165-75. PubMed ID: 196268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Opiate receptors, endorphins and their antagonists].
    Papin AA; Karelin AA
    Anesteziol Reanimatol; 1984; (3):52-61. PubMed ID: 6148029
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of picrotoxin, naloxone, and vagotomy on chlordiazepoxide-induced respiratory depression.
    Billingsley M; Suria A; Williams J
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):95-103. PubMed ID: 543751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of naloxone on the hering-breuer apnea in sleeping kittens.
    Chow CM; Read DJ
    J Appl Physiol Respir Environ Exerc Physiol; 1984 May; 56(5):1278-82. PubMed ID: 6327584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged mu- and delta-receptor occupancy may result in naloxone-reversible respiratory depression and naloxone-irreversible antinociception.
    Freye E; Schenk G
    Prog Clin Biol Res; 1990; 328():379-84. PubMed ID: 2154797
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of centrally administered naloxone on phrenic nerve activity.
    Wilson BA; Eldridge FL; Millhorn DE; Waldrop TG; Klingler LE
    Brain Res; 1984 Dec; 324(2):366-8. PubMed ID: 6529627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central opiate receptor blockade by naloxone impairs thalamic and hypothalamic autoregulation in the cat.
    Komjáti K; Dallos G; Velkei MH; Sándor P
    Pflugers Arch; 1997 May; 434(1):144-6. PubMed ID: 9190560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opiate receptor mediation of ketamine analgesia.
    Finck AD; Ngai SH
    Anesthesiology; 1982 Apr; 56(4):291-7. PubMed ID: 6278991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "other" respiratory effect of opioids: suppression of spontaneous augmented ("sigh") breaths.
    Bell HJ; Azubike E; Haouzi P
    J Appl Physiol (1985); 2011 Nov; 111(5):1296-303. PubMed ID: 21868678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacodynamic effects of S-(+)-ketamine on EEG, evoked potentials and respiration. A study in the awake dog].
    Freye E; Latasch L; Schmidhammer H
    Anaesthesist; 1992 Sep; 41(9):527-33. PubMed ID: 1416007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the mechanism of the interaction of ketamine and halothane in vitro.
    Bansinath M; Warner W; Tang CK; Turndorf H; Puig MM
    Gen Pharmacol; 1992 Nov; 23(6):1183-7. PubMed ID: 1336751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-methyl-D-aspartate (NMDA) receptors control respiratory off-switch in cat.
    Foutz AS; Champagnat J; Denavit-Saubié M
    Neurosci Lett; 1988 May; 87(3):221-6. PubMed ID: 2837690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral versus central cardiorespiratory effects of morphine.
    Willette RN; Sapru HN
    Neuropharmacology; 1982 Oct; 21(10):1019-26. PubMed ID: 6292766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of naloxone with mu- and delta-opioid agonists on the respiration of rats.
    Pazos A; Flórez J
    Eur J Pharmacol; 1983 Feb; 87(2-3):309-14. PubMed ID: 6301857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Respiratory effects of naloxone].
    Carreira-Monteiro ME; Jiménez-Vargas J
    Rev Esp Fisiol; 1985 Jun; 41(2):187-93. PubMed ID: 2994182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.